DEBILINE 50 MG
PEPSIN : 50 MG DEOXYCHOLIC ACID : 100 MG · DIN 00145491 · LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC.
Health Canada status: CANCELLED POST MARKET
What is DEBILINE?
DEBILINE 50 MG contains PEPSIN : 50 MG DEOXYCHOLIC ACID : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00145491, held by LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 28-Sep-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00145491 |
|---|---|
| Brand name | DEBILINE |
| Generic / active ingredient | PEPSIN : 50 MG DEOXYCHOLIC ACID : 100 MG |
| Manufacturer | LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC. |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Ethical |
| ATC code | A09AC01 PEPSIN AND ACID PREPARATIONS |
| AHFS class | 56:16.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 28-Sep-1999 |
| Original market date | 1951-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A09AC01 PEPSIN AND ACID PREPARATIONS. 0 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BEMOSIN TAB | 130 MG | TABLET | THERAPEUTIC FOODS CO. | CANCELLED POST MARKET | DIN 00482412 |
| BETAINE HCL AND PEPSIN | 135 MG | TABLET | RHEINGOLD FOOD INTERNATIONAL LTD. | CANCELLED POST MARKET | DIN 00633690 |
| BETASIN TAB | 97.2 MG | TABLET | BIO VITA | CANCELLED POST MARKET | DIN 00742279 |
| DEBILINE H | 50 MG | TABLET | LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00145653 |
| GLUTAMIC ACID HCL BETAINE HCL W PEPSIN | 200 MG | TABLET | NU-LIFE NUTRITION LTD. | CANCELLED POST MARKET | DIN 00348716 |
| GLUTAMIC ACID HYDROCHLORIDE NU LIFE | 500 MG | TABLET | NU-LIFE NUTRITION LTD. | CANCELLED POST MARKET | DIN 00064173 |
| GLUTAMIC ACID PEPSIN AND BETAINE TABLETS | 10 MG | TABLET | JAMIESON LABORATORIES LTD | CANCELLED POST MARKET | DIN 00123285 |
| STOMACH AID-DIGESTIVE AID | 250 MG | TABLET | NU-LIFE NUTRITION LTD. | CANCELLED POST MARKET | DIN 00709530 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.